Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Keystone

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The American Journal of the Medical Sciences|March 1, 1976
Immunochemical and physical studies of the Sia testE Keystone, W Pruzanski
Rheumatic Diseases Clinics of North America|February 1, 1996
Biologic agents for the treatment of rheumatoid arthritisV Strand, E Keystone, F Breedveld
Rheumatic Diseases Clinics of North America|August 26, 1998
IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritisE Keystone, J Wherry, P Grint
Harefuah|April 16, 1989
[Dermatomyositis associated with normal serum muscle enzyme levels]D Buskila, E Keystone, S Sukenik
Annals of Plastic Surgery|May 1, 1994
Factors affecting the rupture of silicone-gel breast implantsW Peters, E Keystone, D Smith
Current Pharmaceutical Biotechnology|July 27, 2001
Biologic agents in the treatment of rheumatoid arthritisB Haraoui, V Strand, E Keystone
AJNR. American Journal of Neuroradiology|September 26, 2000
Granulomatous hypophysitis due to Wegener's granulomatosisM Goyal, W Kucharczyk, E Keystone
Clinical Therapeutics|January 5, 2002
Current and emerging therapies for rheumatoid arthritis, with a focus on infliximab: clinical impact on joint damage and cost of care in canadaA Russell, B Haraoui, E Keystone, et al.
Reviews of Infectious Diseases|March 1, 1988
Parotitis due to anaerobic bacteriaA Matlow, R Korentager, E Keystone, et al.
Rheumatic Diseases Clinics of North America|August 26, 1998
Biologic agents and immunotherapy in rheumatoid arthritis. Progress and perspectiveW J Wallis, D E Furst, V Strand, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The American Journal of the Medical Sciences|March 1, 1976
Immunochemical and physical studies of the Sia testE Keystone, W Pruzanski
Rheumatic Diseases Clinics of North America|February 1, 1996
Biologic agents for the treatment of rheumatoid arthritisV Strand, E Keystone, F Breedveld
Rheumatic Diseases Clinics of North America|August 26, 1998
IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritisE Keystone, J Wherry, P Grint
Harefuah|April 16, 1989
[Dermatomyositis associated with normal serum muscle enzyme levels]D Buskila, E Keystone, S Sukenik
Annals of Plastic Surgery|May 1, 1994
Factors affecting the rupture of silicone-gel breast implantsW Peters, E Keystone, D Smith
Current Pharmaceutical Biotechnology|July 27, 2001
Biologic agents in the treatment of rheumatoid arthritisB Haraoui, V Strand, E Keystone
AJNR. American Journal of Neuroradiology|September 26, 2000
Granulomatous hypophysitis due to Wegener's granulomatosisM Goyal, W Kucharczyk, E Keystone
Clinical Therapeutics|January 5, 2002
Current and emerging therapies for rheumatoid arthritis, with a focus on infliximab: clinical impact on joint damage and cost of care in canadaA Russell, B Haraoui, E Keystone, et al.
Reviews of Infectious Diseases|March 1, 1988
Parotitis due to anaerobic bacteriaA Matlow, R Korentager, E Keystone, et al.
Rheumatic Diseases Clinics of North America|August 26, 1998
Biologic agents and immunotherapy in rheumatoid arthritis. Progress and perspectiveW J Wallis, D E Furst, V Strand, et al.
Pageof 4